Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Jun J Mao, Geetha Gopalakrishna Pillai, Carlos Jose Andrade, Jennifer A Ligibel, Partha Basu, Lorenzo Cohen, Ikhlas A Khan, Karen M Mustian, Rammanohar Puthiyedath, Kartar Singh Dhiman, Lixing Lao, Ricardo Ghelman, Paulo Cáceres Guido, Gabriel Lopez, Daniel F Gallego-Perez, Luis Alejandro Salicrup, Jun J Mao, Geetha Gopalakrishna Pillai, Carlos Jose Andrade, Jennifer A Ligibel, Partha Basu, Lorenzo Cohen, Ikhlas A Khan, Karen M Mustian, Rammanohar Puthiyedath, Kartar Singh Dhiman, Lixing Lao, Ricardo Ghelman, Paulo Cáceres Guido, Gabriel Lopez, Daniel F Gallego-Perez, Luis Alejandro Salicrup

Abstract

The increase in cancer incidence and mortality is challenging current cancer care delivery globally, disproportionally affecting low- and middle-income countries (LMICs) when it comes to receiving evidence-based cancer prevention, treatment, and palliative and survivorship care. Patients in LMICs often rely on traditional, complementary, and integrative medicine (TCIM) that is more familiar, less costly, and widely available. However, spheres of influence and tensions between conventional medicine and TCIM can further disrupt efforts in evidence-based cancer care. Integrative oncology provides a framework to research and integrate safe, effective TCIM alongside conventional cancer treatment and can help bridge health care gaps in delivering evidence-informed, patient-centered care. This growing field uses lifestyle modifications, mind and body therapies (eg, acupuncture, massage, meditation, and yoga), and natural products to improve symptom management and quality of life among patients with cancer. On the basis of this review of the global challenges of cancer control and the current status of integrative oncology, the authors recommend: 1) educating and integrating TCIM providers into the cancer control workforce to promote risk reduction and culturally salient healthy life styles; 2) developing and testing TCIM interventions to address cancer symptoms or treatment-related adverse effects (eg, pain, insomnia, fatigue); and 3) disseminating and implementing evidence-based TCIM interventions as part of comprehensive palliative and survivorship care so patients from all cultures can live with or beyond cancer with respect, dignity, and vitality. With conventional medicine and TCIM united under a cohesive framework, integrative oncology may provide citizens of the world with access to safe, effective, evidence-informed, and culturally sensitive cancer care.

Keywords: alternative; and integrative medicine; cancer prevention; complementary; global health; health policy; survivorship.

© 2021 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.

References

    1. Ferlay J, Laversanne M, Ervik M, et al. Global Cancer Observatory: Cancer Tomorrow. International Agency for Research on Cancer; 2020. Accessed May 12, 2021.
    1. Gelband H, Sankaranarayanan R, Gauvreau CL, et al. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016;387:2133-2144.
    1. Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv. 2011;5:8-17.
    1. World Health Organization (WHO). Programme on Traditional Medicine. WHO traditional medicine strategy 2002-2005. WHO; 2002. Accessed May 13, 2021.
    1. Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11:187-203.
    1. Trimble EL, Rajaraman P. Integrating traditional and allopathic medicine: an opportunity to improve global health in cancer. J Natl Cancer Inst Monogr. 2017;2017:Igx011.
    1. World Health Organization (WHO). WHO traditional medicine strategy: 2014-2023. WHO; 2013. Accessed January 10, 2021.
    1. Department of Primary Care, Office of Health Care, Ministry of Health of Brazil. National Policy on Integrative and Complementary Practices (PNPIC) of the Unified Health System (SUS): Access Expansion Initiative/Ministry of Health of Brazil, Secretary of Health Care, Department of Primary Care. Ministry of Health of Brazil; 2008.
    1. Witt CM, Balneaves LG, Cardoso MJ, et al. A comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr. 2017;2017:Igx012.
    1. Ferlay J, Ervik M, Lam F, et al, eds. Global Cancer Observatory: Cancer Today. Agency for Research on Cancer; 2020. Accessed November 26, 2020.
    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249.
    1. American Cancer Society. Global Cancer Facts & Figures. 4th ed. American Cancer Society; 2018. Accessed March 30, 2021.
    1. Wild CP, Weiderpass E, Stewart BW, eds. World Cancer Report: Cancer Research for Cancer Prevention. International Agency for Research on Cancer; 2020. Accessed May 12, 2021.
    1. Knaul F, Frenk J, Shulman L. Closing the cancer divide: a blueprint to expand access in low- and middle-income countries. Harvard Global Equity Initiative, November 2011, Boston, MA. Accessed November 26, 2020.
    1. United Nations. Resolution adopted by the General Assembly on 25 September 2015: Transforming Our World: The 2030 Agenda for Sustainable Development. Accessed December 1, 2020.
    1. Soerjomataram I, Lortet-Tieulent J, Ferlay J, et al. Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Med Res Methodol. 2012;12:125.
    1. Martinez R, Lloyd-Sherlock P, Soliz P, et al. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study. Lancet Glob Health. 2020;8:e511-e523.
    1. World Health Organization. Tobacco. Accessed October 21, 2021.
    1. World Health Organization (WHO). WHO reports progress in the fight against tobacco epidemic. Accessed October 21, 2021.
    1. GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389:1885-1906.
    1. O'Hara GA, McNaughton AL, Maponga T, et al. Hepatitis B virus infection as a neglected tropical disease. PLoS Negl Trop Dis. 2017;11:e0005842.
    1. Asiki G, Newton R, Marions L, Seeley J, Kamali A, Smedman L. The impact of maternal factors on mortality rates among children under the age of five years in a rural Ugandan population between 2002 and 2012. Acta Paediatr. 2016;105:191-199.
    1. Bruni L, Saura-Lazaro A, Montoliu A, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019. Prev Med. 2021;144:106399.
    1. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004;7:187-200.
    1. Defo BK. Demographic, epidemiological, and health transitions: are they relevant to population health patterns in Africa? Glob Health Action. 2014;7:22443.
    1. Holmboe-Ottesen G, Wandel M. Changes in dietary habits after migration and consequences for health: a focus on South Asians in Europe. Food Nutr Res. 2012;56. doi:10.3402/fnr.v56i0.18891
    1. Shah SC, Kayamba V, Peek RM Jr, Heimburger D. Cancer control in low- and middle-income countries: is it time to consider screening? J Glob Oncol. 2019;5:1-8.
    1. Linos E, Spanos D, Rosner BA, et al. Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst. 2008;100:1352-1360.
    1. Mathur P, Sathishkumar K, Chaturvedi M, et al. Cancer statistics, 2020: report from National Cancer Registry Programme, India. JCO Glob Oncol. 2020;6:1063-1075.
    1. Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE. Breast cancer in Brazil: present status and future goals. Lancet Oncol. 2012;13:e95-e102.
    1. Rtveladze K, Marsh T, Webber L, et al. Health and economic burden of obesity in Brazil. PLoS One. 2013;8:368785.
    1. Gopal S, Sharpless NE. Cancer as a global health priority. JAMA. 2021;326:809-810.
    1. International Atomic Energy Agency. Directory of Radiotherapy Centres (DIRAC). Accessed March 30, 2020.
    1. Ward ZJ, Atun R, Hricak H, et al. The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis. Lancet Oncol. 2021;22:1301-1311.
    1. Mclntyre D. Learning from Experience: Healthcare Financing in Low and Middle-Income Countries. Global Forum for Health Research; 2007.
    1. Ataguba JE. Reassessing catastrophic health-care payments with a Nigerian case study. Health Econ Policy Law. 2012;7:309-326.
    1. ACTION Study Group. Policy and priorities for national cancer control planning in low- and middle-income countries: lessons from the Association of Southeast Asian Nations (ASEAN) Costs in Oncology prospective cohort study. Eur J Cancer. 2017;74:26-37.
    1. Afungchwi GM, Hesseling PB, Ladas EJ. The role of traditional healers in the diagnosis and management of Burkitt lymphoma in Cameroon: understanding the challenges and moving forward. BMC Complement Altern Med. 2017;17:209.
    1. World Health Organization (WHO). World Report on Aging and Health. WHO; 2015. Accessed March 3, 2021.
    1. Gallicchio L, Tonorezos E, de Moor JS, et al. Evidence gaps in cancer survivorship care: a report from the 2019 National Cancer Institute Cancer survivorship workshop. J Natl Cancer Inst. 2021;113:1136-1142.
    1. Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst. 2019;111:1120-1130.
    1. Viscuse PV, Price K, Millstine D, Bhagra A, Bauer B, Ruddy KJ. Integrative medicine in cancer survivors. Curr Opin Oncol. 2017;29:235-242.
    1. Geerse OP, Lakin JR, Berendsen AJ, Alfano CM, Nekhlyudov L. Cancer survivorship and palliative care: shared progress, challenges, and opportunities. Cancer. 2018;124:4435-4441.
    1. World Health Organization. Sixty-Seventh World Health Assembly, 2014. Strengthening of palliative care as a component of comprehensive care throughout the life course. Accessed October 5, 2021.
    1. International Narcotics Control Board (INCB). Narcotic drugs-Technical Report: Estimated World Requirements for 2020-Statistics for 2018. Accessed March 30, 2020.
    1. Kumar S. Models of delivering palliative and end-of-life care in India. Curr Opin Support Palliat Care. 2013;7:216-222.
    1. Li J, Davis MP, Gamier P. Palliative medicine: barriers and developments in mainland China. Curr Oncol Rep. 2011;13:290-294.
    1. Rhee JY, Luyirika E, Namisango E, et al. APCA Atlas of Palliative Care in Africa. Accessed April 8, 2021.
    1. American Association for the Advancement of Science. The art and science of traditional medicine part 1: TCM today-a case for integration. Science. 2014;346:1564-1569.
    1. Caceres Guido P, Ribas A, Gaioli M, Quattrone F, Macchi A. The state of the integrative medicine in Latin America: the long road to include complementary, natural, and traditional practices in formal health systems. Eur J Integr Med. 2015;7:5-12.
    1. Lopez-Gil S, Nuno-Lambarri N, Chavez-Tapia N, Uribe M, Barbero-Becerra VJ. Liver toxicity mechanisms of herbs commonly used in Latin America. Drug Metab Rev. 2017;49:338-356.
    1. de Moraes Mello Boccolini P, Siqueira Boccolini C. Prevalence of complementary and alternative medicine (CAM) use in Brazil. BMC Complement Med Ther. 2020;20:51.
    1. Rocha V, Ladas EJ, Lin M, et al. Beliefs and determinants of use of traditional complementary/alternative medicine in pediatric patients who undergo treatment for cancer in South America. J Glob Oncol. 2017;3:701-710.
    1. Rojas T, Bourdy G, Ruiz E, et al. Herbal medicine practices of patients with liver cancer in Peru: a comprehensive study toward integrative cancer management. Integr Cancer Ther. 2018;17:52-64.
    1. Samano ES, Goldenstein PT, Ribeiro Lde M, et al. Praying correlates with higher quality of life: results from a survey on complementary/alternative medicine use among a group of Brazilian cancer patients. Sao Paulo Med J. 2004;122:60-63.
    1. Idoyaga Molina A, Luxardo N. [Nonconventional therapies in cancer]. Medicina (B Aires). 2005;65:390-394.
    1. Gerson-Cwilich R, Serrano-Olvera A, Villalobos-Prieto A. Complementary and alternative medicine (CAM) in Mexican patients with cancer. Clin Transl Oncol. 2006;8:200-207.
    1. Tovey P, de Barros NF, Hoehne EL, Carvalheira JB. Use of traditional medicine and globalized complementary and alternative medicine among low-income cancer service users in Brazil. Integr Cancer Ther. 2006;5:232-235.
    1. Gomez-Martinez R, Tlacuilo-Parra A, Garibaldi-Covarrubias R. Use of complementary and alternative medicine in children with cancer in Occidental, Mexico. Pediatr Blood Cancer. 2007;49:820-823.
    1. Ladas EJ, Rivas S, Ndao D, et al. Use of traditional and complementary/alternative medicine (TCAM) in children with cancer in Guatemala. Pediatr Blood Cancer. 2014;61:687-692.
    1. Sanchez R, Ibanez C, Suarez A. [Use of complementary and alternative therapies in children with cancer]. Rev Salud Publica (Bogota). 2015;17:699-712.
    1. Lopez G, Salas CA, Cadiz F, et al. Complementary and integrative medicine use in individuals seeking conventional medical oncology care in Chile: prevalence and patient characteristics. J Glob Oncol. 2019;5:1-6.
    1. Fundacion para Combatir la Leucemia (FUNDALEU). Medicina Integrativa. Accessed November 26, 2020.
    1. Fundacion Arturo Lopez Perez. Terapias complementarias. Accessed August 23, 2021.
    1. BVS MTCI Americas. Jornada Internacional de Medicina Integrativa en el Hospital Calvo Mackenna, Chile. Accessed August 23, 2021.
    1. Hospital Israelita Albert Einstein. Supplementary Therapies. Accessed November 26, 2020.
    1. Brazilian Academic Consortium for Integrative Health. Brazilian Academic Consortium for Integrative Health (CABSIn). Accessed November 26, 2020.
    1. D'Alessandro E, de Brito C, Cecatto R, Saul M, Atta JA, Lin CA. Evaluation of acupuncture for cancer symptoms in a cancer institute in Brazil. Acupunct Med. 2013;31:23-26.
    1. Costa PT, Junior FS, Nascimento PL, et al. Use of complementary and alternative therapies in patients with lymphoma-a vision about what happens in the northeast of Brazil. Hematol Oncol. 2015;33:280.
    1. Trondle M, Stritter W, Ghelman R, Odone V, Seifert G. Broadening the horizon for children's health-a qualitative study on the Centro Latino-Americano de Medicina Integrativa Pediatrica. Complement Ther Med. 2021;58:102681.
    1. Secretaria de Atencao Primaria a Saude, Ministerio da Saude, Brasil. Politica Nacional de Praticas Integrativas e Complementares no SUS. Accessed November 26, 2020.
    1. Ferraz IS, Climaco LCC, dos Santos Almeida J, Aragao SA, dos Reis LA, Filho IEM. Expansao das praticas integrativas e complementares no Brasil e o processo de implantacao no sistema unico de saude. Enfermeria Actual de Costa Rica. 2020;38:196-208.
    1. Ministerio da Saude. Praticas Integrativas e Complementares (PICS): Quais sao e para que servem. Accessed May 12, 2021.
    1. Stubbe DE. Complementary and alternative medicine: if you don't ask, they won't tell. Focus (Am Psychiatr Publ). 2018;16:60-62.
    1. Yeung KS, Gubili J, Mao JJ. Herb-drug interactions in cancer care. Oncology (Williston Park). 2018;32:516-520.
    1. Fernandez T, Cerda Zolezzi P, Aulicino P, et al. Immunobiological features of the galactoside lectin L-Lc isolated from the Argentine mistletoe Ligaria cuneifolia. J Ethnopharmacol. 2003;85:81-92.
    1. Barni MV, Carlini MJ, Cafferata EG, Puricelli L, Moreno S. Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells. Oncol Rep. 2012;27:1041-1048.
    1. Malvicini M, Gutierrez-Moraga A, Rodriguez MM, et al. A tricin derivative from Deschampsia antarctica Desv. inhibits colorectal carcinoma growth and liver metastasis through the induction of a specific immune response. Mol Cancer Ther. 2018;17:966-976.
    1. Qazi AK, Siddiqui JA, Jahan R, et al. Emerging therapeutic potential of graviola and its constituents in cancers. Carcinogenesis. 2018;39:522-533.
    1. Tauchen J, Huml L, Bortl L, et al. Screening of medicinal plants traditionally used in Peruvian Amazon for in vitro antioxidant and anticancer potential. Nat Prod Res. 2019;33:2718-2721.
    1. Sitarek P, Merecz-Sadowska A, Sliwinski T, Zajdel R, Kowalczyk T. An in vitro evaluation of the molecular mechanisms of action of medical plants from the Lamiaceae family as effective sources of active compounds against human cancer cell lines. Cancers (Basel). 2020;12:2957.
    1. de Paula LC, Fonseca F, Perazzo F, et al. Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors. J Altern Complement Med. 2015;21:22-30.
    1. Santos Araujo MdC, Farias IL, Gutierres J, et al. Uncaria tomentosa-adjuvant treatment for breast cancer: clinical trial. Evid Based Complement Alternat Med. 2012;2012:676984.
    1. Palma CG, Lera AT, Lerner T, et al. Guarana (Paullinia cupana) improves anorexia in patients with advanced cancer. J Diet Suppl. 2016;13:221-231.
    1. del Giglio AB, Cubero DdIG, Lerner TG, et al. Purified dry extract of Paullinia cupana (guarana) (PC-18) for chemotherapy-related fatigue in patients with solid tumors: an early discontinuation study. J Diet Suppl. 2013;10:325-334.
    1. de Oliveira Campos MP, Riechelmann R, Martins LC, Hassan BJ, Casa FB, Del Giglio A. Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy. J Altern Complement Med. 2011;17:505-512.
    1. Ly A. Traditional medicines and cancer therapies in African landscape. J Tumor Med Prev. 2018;3:555601.
    1. Livingston J. Improvising Medicine: An African Oncology Ward in an Emerging Cancer Epidemic. Duke University Press; 2012.
    1. Ly A. Global health, cancer challenges and control in African settings. Cancer Ther Oncol Int J. 2016;2:555587.
    1. Raimi IO, Kopaopa BG, Mugivhisa LL, Lewu FB, Amoo SO, Olowoyo JO. An appraisal of documented medicinal plants used for the treatment of cancer in Africa over a twenty-year period (1998-2018). J Herb Med. 2020;23:100371.
    1. Alegbeleye BJ, Akpoveso OOP, Mohammed RK. The use of herbal medicines by cancer patients in contemporary African settings: a scoping review. Int J Sci Adv. 2020;1:49-73.
    1. Asiimwe JB, Nagendrappa PB, Atukunda EC, et al. Prevalence of the use of herbal medicines among patients with cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2021;2021:9963038.
    1. Aliyu UM, Awosan KJ, Oche MO, Taiwo AO, Jimoh AO, Okuofo EC. Prevalence and correlates of complementary and alternative medicine use among cancer patients in Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria. Niger J Clin Pract. 2017;20:1576-1583.
    1. Labidi S, Ennouri S, Rachdi H, et al. Use of complementary and alternative medicine in cancer: a Tunisian single-center experience. Bull Cancer. 2020;107:209-214.
    1. Brahmi SA, El M'rabet FZ, Benbrahim Z, et al. Complementary medicine use among Moroccan patients with cancer: a descriptive study. Pan Afr Med J. 2011;10:36.
    1. Broom A, Nayar K, Tovey P, et al. Indian cancer patients' use of traditional, complementary and alternative medicine (TCAM) and delays in presentation to hospital. Oman Med J. 2009;24:99-102.
    1. Kumar D, Goel NK, Pandey AK, Sarpal SS. Complementary and alternative medicine use among the cancer patients in Northern India. South Asian J Cancer. 2016;5:8-11.
    1. Shetty N, Rai PR, Shetty A. Study of the use of traditional, complementary, and alternative medicine in Indian cancer patients. Indian J Med Paediatr Oncol. 2019;40:365-368.
    1. Lim EJ, Vardy JL, Oh BS, Dhillon HM. A scoping review on models of integrative medicine: what is known from the existing literature? J Altern Complement Med. 2017;23:8-17.
    1. Deshmukh V, Kulkarni A, Bhargava S, et al. Effectiveness of combinations of Ayurvedic drugs in alleviating drug toxicity and improving quality of life of cancer patients treated with chemotherapy. Support Care Cancer. 2014;22:3007-3015.
    1. Giordano A, Tommonaro G. Curcumin and cancer. Nutrients. 2019;11:2376.
    1. Palliyaguru DL, Singh SV, Kensler TW. Withania somnifera: from prevention to treatment of cancer. Mol Nutr Food Res. 2016;60:1342-1353.
    1. Girdhani S, Bhosle SM, Thulsidas SA, Kumar A, Mishra KP. Potential of radiosensitizing agents in cancer chemo-radiotherapy. J Cancer Res Ther. 2005;1:129-131.
    1. Aggarwal BB, Ichikawa H, Garodia P, et al. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets. 2006;10:87-118.
    1. Choedon T, Shukla SK, Kumar V. Chemopreventive and anti-cancer properties of the aqueous extract of flowers of Butea monosperma. J Ethnopharmacol. 2010;129:208-213.
    1. Kumar DR, George VC, Suresh PK, Kumar RA. Cancer-specific chemoprevention and anti-metastatic potentials of Rheum emodi rhizome ethyl acetate extracts and identification of active principles through HPLC and GC-MS analysis. Pak J Pharm Sci. 2015;28:83-93.
    1. Tiloke C, Anand K, Gengan RM, Chuturgoon AA. Moringa oleifera and their phytonanoparticles: potential antiproliferative agents against cancer. Biomed Pharmacother. 2018;108:457-466.
    1. Vyas P, Thakar AB, Baghel MS, Sisodia A, Deole Y. Efficacy of Rasayana Avaleha as adjuvant to radiotherapy and chemotherapy in reducing adverse effects. Ayu. 2010;31:417-423.
    1. Communication Strategy Research Office, Center for International Communication Studies. 2015 China National Image Global Survey. China Foreign Languages Publishing Administration; 2015. Accessed March 30, 2021.
    1. Chen Z, Gu K, Zheng Y, Zheng W, Lu W, Shu XO. The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med. 2008;14:1049-1055.
    1. McQuade JL, Meng Z, Chen Z, et al. Utilization of and attitudes towards traditional Chinese medicine therapies in a Chinese cancer hospital: a survey of patients and physicians. Evid Based Complement Alternat Med. 2012;2012:504507.
    1. Chen G, Qiao TT, Ding H, et al. Use of Chinese herbal medicine therapies in comprehensive hospitals in central China: a parallel survey in cancer patients and clinicians. J Huazhong Univ Sci Technolog Med Sci. 2015;35:808-814.
    1. China's State Council Information Office. 2016 White Paper: Traditional Chinese Medicine in China. Accessed April 28, 2018.
    1. Wu M, Lu P, Shi L, Li S. Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis. Oncotarget. 2015;6:38283-38295.
    1. Chinese Medicine Council of Hong Kong. Development of Chinese Medicine in Hong Kong. Accessed December 31, 2021.
    1. Ng SS, Leung WW, Mak TW, et al. Electroacupuncture reduces duration of postoperative ileus after laparoscopic surgery for colorectal cancer. Gastroenterology. 2013;144:307-313.e301.
    1. Zeng Y, Cheng ASK, Song T, et al. Effects of acupuncture on cancer-related cognitive impairment in Chinese gynecological cancer patients: a pilot cohort study. Integr Cancer Ther. 2018;17:737-746.
    1. Molassiotis A, Suen LKP, Cheng HL, et al. A randomized assessor-blinded wait-list-controlled trial to assess the effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Integr Cancer Ther. 2019;18:1534735419836501.
    1. Tian G, Zhao C, Zhang X, et al. Evidence-based traditional Chinese medicine research: two decades of development, its impact, and breakthrough. J Evid Based Med. 2021;14:65-74.
    1. Xu Y, Mao JJ, Sun L, et al. Association between use of traditional Chinese medicine herbal therapy and survival outcomes in patients with stage II and III colorectal cancer: a multicenter prospective cohort study. J Natl Cancer Inst Monogr. 2017;2017:Igx015.
    1. Xu Y, Wang XS, Chen Y, Shi Q, Chen TH, Li P. A phase II randomized controlled trial of Renshen Yangrong Tang herbal extract granules for fatigue reduction in cancer survivors. J Pain Symptom Manag. 2020;59:966-973.
    1. He Y, Guo X, May BH, et al. Clinical evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis. JAMA Oncol. 2020;6:271-278.
    1. Liu J, Mao JJ, Wang XS, Lin H. Evaluation of traditional Chinese medicine herbs in oncology clinical trials. Cancer J. 2019;25:367-371.
    1. Sun L, Mao JJ, Vertosick E, Seluzicki C, Yang Y. Evaluating cancer patients' expectations and barriers toward traditional Chinese medicine utilization in China: a patient-support group-based cross-sectional survey. Integr Cancer Ther. 2018;17:885-893.
    1. Division of Cancer Treatment and Diagnosis, Office of Cancer Complementary and Alternative Medicine (OCCAM), National Cancer Institute (NCI). NCI CAM History and the Role of OCCAM. Accessed April 6, 2021.
    1. Yun H, Sun L, Mao JJ. Growth of integrative medicine at leading cancer centers between 2009 and 2016: a systematic analysis of NCI-designated Comprehensive Cancer Center websites. J Natl Cancer Inst Monogr. 2017;2017;Igx004.
    1. Greenlee H, Balneaves LG, Carlson LE, et al. Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr. 2014;2014:346-358.
    1. Greenlee H, DuPont-Reyes MJ, Balneaves LG, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017;67:194-232.
    1. Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36:2647-2655.
    1. National Comprehensive Cancer Network (NCCN). NCCN Guidelines: Supportive Care. Accessed May 27, 2021.
    1. Denlinger CS, Sanft T, Armenian S, et al. NCCN Clinical Practice Guidelines in Oncology: Survivorship. Version 1.2021. Accessed May 27, 2021.
    1. Swarm RA, Youngwerth JM, Anghelescu DL, Madhuri A, Buga S, Chwistek M. NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain. Version 1.2021. Accessed May 27, 2021.
    1. Berger AM, Mooney K, Aranha O, et al. NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. Version 1.2021. Accessed March 17, 2021.
    1. Ettinger DS, Berger MJ, Anand S, et al. NCCN Clinical Practice Guidelines in Oncology: Antiemesis. Version 1.2021. Accessed March 17, 2021.
    1. Riba MB, Donovan KA, Ahmed K, Andersen B, Braun I, Breitbart WS. NCCN Clinical Practice Guidelines in Oncology: Distress Management. Version 2.2021. Accessed May 27, 2021.
    1. Dans M, Kutner JS, Agarwal R, Baker JN, Bauman JR. NCCN Clinical Practice Guidelines in Oncology: Palliative Care. Version 2.2021. Accessed May 27, 2021.
    1. Jiang H, Livingston M, Room R, Chenhall R, English DR. Temporal associations of alcohol and tobacco consumption with cancer mortality. JAMA Netw Open. 2018;1:e180713.
    1. Jeon J, Holford TR, Levy DT, et al. Smoking and lung cancer mortality in the United States From 2015 to 2065: a comparative modeling approach. Ann Intern Med. 2018;169:684-693.
    1. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328:1519.
    1. World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. A Summary of the Third Expert Report. Accessed May 27, 2021.
    1. LoConte NK, Brewster AM, Kaur JS, Merrill JK, Alberg AJ. Alcohol and cancer: a statement of the American Society of Clinical Oncology. J Clin Oncol. 2018;36:83-93.
    1. American Association for Cancer Research(AACR). AACR Cancer Progress Report 2020. Accessed December 1, 2020.
    1. Zhang YB, Pan XF, Chen J, et al. Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies. Br J Cancer. 2020;122:1085-1093.
    1. Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer-viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794-798.
    1. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546.
    1. Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118:1130-1141.
    1. Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68:31-54.
    1. Brenner DR, Poirier AE, Ruan Y, et al. Estimates of the current and future burden of cancer attributable to excess body weight and abdominal adiposity in Canada. Prev Med. 2019;122:49-64.
    1. Ligibel JA, Alfano CM, Courneya KS, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32:3568-3574.
    1. Gallagher EJ, LeRoith D. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer. Diabetes Care. 2013;36(suppl 2):S233-S239.
    1. Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015;95:727-748.
    1. Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317:2515-2523.
    1. Hsu WC, Araneta MR, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38:150-158.
    1. Look AHEAD Research Group; Yeh HC, Bantle JP, et al. Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD randomized clinical trial. Obesity (Silver Spring). 2020;28:1678-1686.
    1. Gilchrist SC, Howard VJ, Akinyemiju T, et al. Association of sedentary behavior with cancer mortality in middle-aged and older US adults. JAMA Oncol. 2020;6:1210-1217.
    1. Nahleh Z, Sivasubramaniam D, Dhaliwal S, Sundarajan V, Komrokji R. Residual cancer burden in locally advanced breast cancer: a superior tool. Curr Oncol. 2008;15:271-278.
    1. Rack B, Andergassen U, Neugebauer J, et al. The German SUCCESS C study-the first European lifestyle study on breast cancer. Breast Care (Basel). 2010;5:395-400.
    1. Ligibel JA, Barry WT, Alfano C, et al. Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. NPJ Breast Cancer. 2017;3:37.
    1. Thomson CA, Crane TE, Miller A, Garcia DO, Basen-Engquist K, Alberts DS. A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): an NRG Oncology/Gynecologic Oncology Group (GOG-225) study. Contemp Clin Trials. 2016;49:181-189.
    1. Courneya KS, Booth CM, Gill S, et al. The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Curr Oncol. 2008;15:279-285.
    1. Bao T, Patil S, Chen C, et al. Effect of acupuncture vs sham procedure on chemotherapy-induced peripheral neuropathy symptoms: a randomized clinical trial. JAMA Netw Open. 2020;3:e200681.
    1. Hu C, Zhang H, Wu W, et al. Acupuncture for pain management in cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2016;2016:1720239.
    1. Paice JA, Portenoy R, Lacchetti C, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2016;34:3325-3345.
    1. Hershman DL, Unger JM, Greenlee H, et al. Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial. JAMA. 2018;320:167-176.
    1. Mao JJ, Liou KT, Baser RE, et al. Effectiveness of electroacupuncture or auricular acupuncture vs usual care for chronic musculoskeletal pain among cancer survivors: the PEACE randomized clinical trial. JAMA Oncol. 2021;7:720-727.
    1. Mao JJ, Bowman MA, Xie SX, Bruner D, DeMichele A, Farrar JT. Electroacupuncture versus gabapentin for hot flashes among breast cancer survivors: a randomized placebo-controlled trial. J Clin Oncol. 2015;33:3615-3620.
    1. Lesi G, Razzini G, Musti MA, et al. Acupuncture as an integrative approach for the treatment of hot flashes in women with breast cancer: a prospective multicenter randomized controlled trial (AcCliMaT). J Clin Oncol. 2016;34:1795-1802.
    1. Walker EM, Rodriguez AI, Kohn B, et al. Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol. 2010;28:634-640.
    1. Mao JJ, Wagner KE, Seluzicki CM, et al. Integrating oncology massage into chemoinfusion suites: a program evaluation. J Oncol Pract. 2017;13:e207-e216.
    1. Smith MC, Reeder F, Daniel L, Baramee J, Hagman J. Outcomes of touch therapies during bone marrow transplant. Altern Ther Health Med. 2003;9:40-49.
    1. Noto Y, Kitajima M, Kudo M, Okudera K, Hirota K. Leg massage therapy promotes psychological relaxation and reinforces the first-line host defense in cancer patients. J Anesth. 2010;24:827-831.
    1. Toth M, Marcantonio ER, Davis RB, Walton T, Kahn JR, Phillips RS. Massage therapy for patients with metastatic cancer: a pilot randomized controlled trial. J Altern Complement Med. 2013;19:650-656.
    1. Krohn M, Listing M, Tjahjono G, et al. Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy. Support Care Cancer. 2011;19:1303-1311.
    1. Donoyama N, Satoh T, Hamano T, Ohkoshi N, Onuki M. Effects of Anma therapy (Japanese massage) on health-related quality of life in gynecologic cancer survivors: a randomized controlled trial. PLoS One. 2018;13:e0196638.
    1. Cassileth BR, Vickers AJ. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manag. 2004;28:244-249.
    1. Soden K, Vincent K, Craske S, Lucas C, Ashley S. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med. 2004;18:87-92.
    1. Listing M, Reisshauer A, Krohn M, et al. Massage therapy reduces physical discomfort and improves mood disturbances in women with breast cancer. Psychooncology. 2009;18:1290-1299.
    1. Kutner JS, Smith MC, Corbin L, et al. Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial. Ann Intern Med. 2008;149:369-379.
    1. Kinkead B, Schettler PJ, Larson ER, et al. Massage therapy decreases cancer-related fatigue: results from a randomized early phase trial. Cancer. 2018;124:546-554.
    1. Boyd C, Crawford C, Paat CF, Price A, Xenakis L, Zhang W. The Impact of massage therapy on function in pain populations-A systematic review and meta-analysis of randomized controlled trials: Part II, cancer pain populations. Pain Med. 2016;17(8):1553-1568. doi:10.1093/pm/pnw100.
    1. Williams AF, Vadgama A, Franks PJ, Mortimer PS. A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. Eur J Cancer Care (Engl). 2002;11:254-261.
    1. Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396.
    1. Ezzo J, Manheimer E, McNeely ML, et al. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev. 2015;5:CD003475.
    1. Wurtzen H, Dalton SO, Elsass P, et al. Mindfulness significantly reduces self-reported levels of anxiety and depression: results of a randomised controlled trial among 336 Danish women treated for stage I-III breast cancer. Eur J Cancer. 2013;49:1365-1373.
    1. Lengacher CA, Reich RR, Paterson CL, et al. Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2016;34:2827-2834.
    1. Andersen SR, Wurtzen H, Steding-Jessen M, et al. Effect of mindfulness-based stress reduction on sleep quality: results of a randomized trial among Danish breast cancer patients. Acta Oncol. 2013;52:336-344.
    1. Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hebert JR. The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. Breast Cancer Res Treat. 2012;131:99-109.
    1. Zainal NZ, Booth S, Huppert FA. The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis. Psychooncology. 2013;22:1457-1465.
    1. Carlson LE, Doll R, Stephen J, et al. Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer. J Clin Oncol. 2013;31:3119-3126.
    1. Bower JE, Partridge AH, Wolff AC, et al. Targeting depressive symptoms in younger breast cancer survivors: the Pathways to Wellness randomized controlled trial of mindfulness meditation and survivorship education. J Clin Oncol. Published online August 18, 2021. doi:10.1200/JCO.21.00279
    1. Bower JE, Woolery A, Sternlieb B, Garet D. Yoga for cancer patients and survivors. Cancer Control. 2005;12:165-171.
    1. Rosenbaum E, Gautier H, Fobair P, et al. Cancer supportive care, improving the quality of life for cancer patients. A program evaluation report. Support Care Cancer. 2004;12:293-301.
    1. Rao MR, Raghuram N, Nagendra HR, et al. Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial. Complement Ther Med. 2009;17:1-8.
    1. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29:448-474.
    1. Vadiraja HS, Raghavendra RM, Nagarathna R, et al. Effects of a yoga program on cortisol rhythm and mood states in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial. Integr Cancer Ther. 2009;8:37-46.
    1. Mustian KM, Sprod LK, Janelsins M, Peppone LJ, Mohile S. Exercise recommendations for cancer-related fatigue, cognitive impairment, sleep problems, depression, pain, anxiety, and physical dysfunction: a review. Oncol Hematol Rev. 2012;8:81-88.
    1. Mustian KM, Sprod LK, Janelsins M, et al. Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol. 2013;31:3233-3241.
    1. Lin PJ, Peppone LJ, Janelsins MC, et al. Yoga for the management of cancer treatment-related toxicities. Curr Oncol Rep. 2018;20:5.
    1. Mustian KM, Cole CL, Lin PJ, et al. Exercise recommendations for the management of symptoms clusters resulting from cancer and cancer treatments. Semin Oncol Nurs. 2016;32:383-393.
    1. Moadel AB, Shah C, Wylie-Rosett J, et al. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life. J Clin Oncol. 2007;25:4387-4395.
    1. Zetzl T, Renner A, Pittig A, Jentschke E, Roch C, van Oorschot B. Yoga effectively reduces fatigue and symptoms of depression in patients with different types of cancer. Support Care Cancer. 2021;29:2973-2982.
    1. Armer JS, Lutgendorf SK. The impact of yoga on fatigue in cancer survivorship: a meta-analysis. JNCI Cancer Spectr. 2020;4:pkz098.
    1. Kiecolt-Glaser JK, Bennett JM, Andridge R, et al. Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32:1040-1049.
    1. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008;26:665-673.
    1. Giovannucci E, Chan AT. Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J Clin Oncol. 2010;28:4081-4085.
    1. Anderson JG, Taylor AG. Use of complementary therapies for cancer symptom management: results of the 2007 National Health Interview Survey. J Altern Complement Med. 2012;18:235-241.
    1. Shipkowski KA, Betz JM, Birnbaum LS, et al. Naturally complex: perspectives and challenges associated with botanical dietary supplement safety assessment. Food Chem Toxicol. 2018;118:963-971.
    1. Bae JY, Avula B, Wang YH, et al. Development and validation of a UHPLC-PDA-MS method for the quantitative analysis of anthraquinones in Bulbine natalensis extracts and dietary supplements. Planta Med. 2020;86:144-150.
    1. Ruiz GG, Nelson EO, Kozin AF, Turner TC, Waters RF, Langland JO. A lack of bioactive predictability for marker compounds commonly used for herbal medicine standardization. PLoS One. 2016;11:e0159857.
    1. Liu J, Hou W, Gonen M, Seluzicki C, Li SQ, Mao JJ. Symptom burden and willingness to participate: implications for herbal clinical trials in lung cancer. Ann Palliat Med. 2021;10:1895-1903.
    1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200-1205.
    1. Hou YN, Deng G, Mao JJ. Practical application of “About Herbs” website: herbs and dietary supplement use in oncology settings. Cancer J. 2019;25:357-366.
    1. Desai AG, Qazi GN, Ganju RK, et al. Medicinal plants and cancer chemoprevention. Curr Drug Metab. 2008;9:581-591.
    1. Xiang Y, He JY, Li R. Appropriateness of sham or placebo acupuncture for randomized controlled trials of acupuncture for nonspecific low back pain: a systematic review and meta-analysis. J Pain Res. 2018;11:83-94.
    1. He W, Tong Y, Zhao Y, et al. Review of controlled clinical trials on acupuncture versus sham acupuncture in Germany. J Tradit Chin Med. 2013;33:403-407.
    1. Lopez G, Lacey J, Christie AJ, et al. Patient-reported outcomes in integrative oncology: bridging clinical care with research. Cancer J. 2019;25:311-315.
    1. MacLeod J, Wolff E, McAllister A, Mao JJ, Garland SN. Including the patient voice in patient-centered outcomes research in integrative oncology. J Natl Cancer Inst Monogr. 2017;2017;Igx008.
    1. Garland SN, Trevino K, Liou KT, et al. Multi-stakeholder perspectives on managing insomnia in cancer survivors: recommendations to reduce barriers and translate patient-centered research into practice. J Cancer Surviv. Published online February 19, 2021. doi:10.1007/s11764-021-01001-1
    1. Ben-Arye E, Schiff E, Zollman C, et al. Integrating complementary medicine in supportive cancer care models across four continents. Med Oncol. 2013;30:511.
    1. Moral-Munoz JA, Carballo-Costa L, Herrera-Viedma E, Cobo MJ. Production trends, collaboration, and main topics of the integrative and complementary oncology research area: a bibliometric analysis. Integr Cancer Ther. 2019;18:1534735419846401.
    1. Grant SJ, Hunter J, Seely D, Balneaves LG, Rossi E, Bao T. Integrative oncology: international perspectives. Integr Cancer Ther. 2019;18:1534735418823266.
    1. Office of Cancer Complementary and Alternative Medicine, National Cancer Institute. International Activities. National Cancer Institute; 2016. Accessed September 12, 2020.
    1. Jia L, Lin H, Oppenheim J, et al. US National Cancer Institute-China collaborative studies on Chinese medicine and cancer. J Natl Cancer Inst Monogr. 2017;2017;Igx007.
    1. Yang M, Feng Y, Zhang YL, et al. Herbal formula MaZiRenWan (hemp seed pill) for constipation: a systematic review with meta-analysis. Phytomedicine. 2021;82:153459.
    1. Yang M, Li SQ, Smith CM, Zhang YL, Bao T, Mao JJ. Tibetan herbal pain-relieving plaster for low back pain: a systematic review and meta-analysis. Biomed Pharmacother. 2021;140:111727.
    1. Liu J, Mao JJ, Li SQ, Lin H. Preliminary efficacy and safety of Reishi & Privet Formula on quality of life among non-small cell lung cancer patients undergoing chemotherapy: a randomized placebo-controlled trial. Integr Cancer Ther. 2020;19:1534735420944491.
    1. Sun L, Mao JJ, Yan Y, Xu Y, Yang Y. Patient reported traditional Chinese medicine spleen deficiency syndrome (TCM-SDS) scale for colorectal cancer: development and validation in China. Integr Cancer Ther. 2021;20:15347354211020105.
    1. Sun L, Yang Y, Vertosick E, Jo S, Sun G, Mao JJ. Do perceived needs affect willingness to use traditional Chinese medicine for survivorship care among Chinese cancer survivors? A cross-sectional survey. J Glob Oncol. 2017;3:692-700.
    1. Gallego-Perez DF, Abdala CVM, Amado DM, Carvalho de Sousa IM, Aldana-Martinez NS, Ghelman R. Equity, intercultural approaches and access to information on traditional, complementary and integrative medicines in the Americas. Rev Panam Salud Publica. 2020;44:e143.
    1. Weeks J. Infrastructure to spur inclusion of traditional, complementary, and integrative medicine: the TCIM Americas Network model inside the Pan American Health Organization. J Altern Complement Med. 2020;26:82-84.
    1. Mao JJ. Advancing the global impact of integrative oncology. J Natl Cancer Inst Monogr. 2017;2017:Igx001.
    1. Sundararajan R, Mwanga-Amumpaire J, King R, Ware NC. Conceptual model for pluralistic healthcare behaviour: results from a qualitative study in southwestern Uganda. BMJ Open. 2020;10:e033410.
    1. World Health Organization (WHO). Global Status Report on Noncommunicable Diseases 2010. WHO; 2011. Accessed March 30, 2021.
    1. Clairet AL, Boiteux-Jurain M, Curtit E, et al. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review. Med Oncol. 2019;36:45.
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Collaborating with Traditional Healers for HIV Prevention and Care in Sub-Saharan Africa: Suggestions for Programme Managers and field Workers. UNAIDS; 2006. Accessed March 30, 2021.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe